Key result
Combining SIT and CCT fails to improve primary aldosteronism subtype prediction over either test alone.
Why the study?
It was unclear whether multiple types of confirmatory tests are more useful than a single type in predicting subtypes of primary aldosteronism.
Does the combination of two confirmatory tests improve performance in predicting subtypes of primary aldosteronism compared to a single test?
Cross-Sectional (n=615)
Yes
Does the combination of two confirmatory tests improve performance in predicting subtypes of primary aldosteronism compared to a single test?
Absolute Event Rate: 0.85% vs 0.813%
Combining multiple confirmatory tests does not significantly improve the prediction of primary aldosteronism subtypes compared to using a single test or baseline clinical characteristics alone.
Combining confirmatory tests adds no value for PA subtyping; leaves open whether alternative strategies merit prospective trials.
OBJECTIVE: The clinical practice guideline for primary aldosteronism (PA) places a high value on confirmatory tests to sparing patients with false-positive results in case detection from undergoing adrenal venous sampling (AVS). However, it is unclear whether multiple types of confirmatory tests are more useful than a single type. To evaluate whether the machine-learned combination of two confirmatory tests is more useful in predicting subtypes of PA than each test alone. DESIGN: A retrospective cross-sectional study in referral centres. PATIENTS: This study included 615 patients with PA randomly assigned to the training and test data sets. The participants underwent saline infusion test (SIT) and captopril challenge test (CCT) and were subtyped by AVS (unilateral, n = 99; bilateral, n = 516). MEASUREMENTS: The area under the curve (AUC) and clinical usefulness using decision curve analysis for the subtype prediction in the test data set. RESULTS: The AUCs for the combination of SIT and CCT, SIT alone and CCT alone were 0.850, 0.813 and 0.786, respectively, with no significant differences between them. The AUC for the baseline clinical characteristics alone was 0.872, whereas the AUCs for these combined with SIT, combined with CCT and combined with both SIT and CCT were 0.868, 0.854 and 0.855, respectively, with no significant improvement in AUC. The additional clinical usefulness of the second confirmatory test was unremarkable on decision curve analysis. CONCLUSIONS: Our data suggest that patients with positive case detection undergo one confirmatory test to determine the indication for AVS.
No takes yet. Share an insight, caveat, or question.
Kaneko et al. (2022) conducted a cross-sectional in Primary aldosteronism (n=615). Combination of saline infusion test (SIT) and captopril challenge test (CCT) vs. SIT alone or CCT alone was evaluated on Area under the curve (AUC) for subtype prediction. Combining saline infusion and captopril challenge tests did not significantly improve AUC for predicting primary aldosteronism subtypes compared to SIT alone (0.850 vs 0.813) or CCT alone (0.786).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: